Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€154.00
29.05.23
-
29.05.24
10.06%
16.08.23

Could be worthwhile Investment >10% per year
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.60
24.07.23
€155.00
24.07.24
3.47%
16.08.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€106.80
16.08.22
-
16.08.23
-2.62%
16.08.23

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€94.03
16.08.22
-
16.08.23
-11.99%
16.08.23

buy
Bayer AG

Start price
Target price
Perf. (%)
€50.42
13.07.23
€60.00
13.08.23
3.91%
14.08.23

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€94.20
11.07.23
-
11.08.23
3.09%
12.08.23

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€79.36
11.08.22
€110.00
11.08.23
22.37%
12.08.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
GSK plc

Start price
Target price
Perf. (%)
€18.77
10.08.22
-
10.08.23
-15.01%
11.08.23

buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€100.76
08.08.22
€120.00
08.08.23
69.31%
09.08.23

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€97.50
07.07.23
-
07.08.23
1.36%
08.08.23

buy
Bayer AG

Start price
Target price
Perf. (%)
€58.91
08.02.23
€67.00
08.08.23
-11.76%
08.08.23

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
buy
Bayer AG

Start price
Target price
Perf. (%)
€50.71
30.06.23
€52.00
30.06.24
3.31%
07.08.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€211.20
23.07.23
-
23.07.24
4.55%
06.08.23

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€167.80
05.08.22
€190.00
05.08.23
-8.34%
06.08.23

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€176.92
03.08.22
€190.00
03.08.23
-6.34%
03.08.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€7.98
20.03.23
-
20.03.24
5.01%
02.08.23

Top 10 in its market
Future proof or reliable business model
buy
Bayer AG

Start price
Target price
Perf. (%)
€54.52
12.08.22
€65.00
12.08.23
-7.80%
24.07.23

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€145.40
11.07.23
€155.00
11.07.24
4.95%
24.07.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Bayer AG

Start price
Target price
Perf. (%)
€55.78
18.07.22
€65.00
18.07.23
-7.42%
19.07.23

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€175.60
13.07.22
€168.00
13.07.23
-19.13%
13.07.23

Novartis AG ADR

Start price
Target price
Perf. (%)
€93.60
12.06.23
-
12.06.24
-6.20%
12.07.23

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€171.94
26.09.22
€150.00
26.09.23
-15.44%
11.07.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
buy
Bayer AG

Start price
Target price
Perf. (%)
€57.27
09.07.22
-
09.07.23
-12.17%
09.07.23

AbbVie Inc.

Start price
Target price
Perf. (%)
€127.30
31.05.23
-
31.05.24
-2.20%
04.07.23